메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background and Objectives This study examined the expressions of p16 and the programmedcell death 1 ligand (PD-L1) in patients with oropharyngeal cancer (OPC) treated withradiotherapy (RT) to identify the correlation between p16 and PD-L1 expression, and to examinethe prognostic significance of these markers for OPC patients receiving RT. Subjects and Method Forty-eight OPC patients diagnosed and treated at a tertiary referralhospital were enrolled in this retrospective analysis. Patients were initially treated with RT orchemoradiotherapy (CRT) with curative intent and completed the planned schedule. Expressionof p16 and PD-L1 by primary tumors was evaluated by immunohistochemistry, and resultswere interpreted separately and dichotomized according to outcome analyses. Results Of the 48 patients, 25 (52.1%) expressed p16 and 15 (31.3%) expressed PD-L1. Expressionof these markers showed a mutual positive correlation (p=0.046). Positive PD-L1 expressionwas associated with poor complete remission (CR) rates after RT (p=0.040). Positivep16 expression was associated with better recurrence-free survival (RFS) (p=0.004) but notoverall survival (OS) (p=0.192). PD-L1 expression showed no independent association withsurvival (p>0.05); however, PD-L1 expression tended toward poorer RFS, even in p16-positiveindividuals. Conclusion There was a positive correlation between the expression of p16 and PD-L1 inOPCs. PD-L1 expression was associated with poorer CR rates after RT or CRT. PD-L1 alonedid not show an association with RFS or OS, but when combined with p16, it tended towardpoorer RFS, even in p16-positive cases.

목차

등록된 정보가 없습니다.

참고문헌 (32)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0